The 2025 Nobel Prize in Medicine has been awarded to American researchers Mary E. Brunko, Fred Ramsdell, and Japanese scientist Shimon Sakaguchi for their groundbreaking discoveries concerning how the body regulates its immune system. The Nobel Committee announced the prestigious award, recognizing their research on “discoveries concerning peripheral immune tolerance.”
Professor Marie Fahren-Härlinius of the Karolinska Institute explained the significance of the award, stating, “This year’s Nobel Prize in Physiology or Medicine focuses on how we control our immune system, enabling us to combat any conceivable microbe while avoiding autoimmune diseases.” A strong immune system is crucial, but it must be meticulously regulated to prevent it from attacking the body’s own tissues.
The Nobel laureates identified the “guardian cells” of the immune system: regulatory T cells (Tregs). These specialized cells prevent other immune cells from attacking the body, maintaining a delicate balance. Their work has laid the foundation for a new field of research and spurred the development of novel therapies for diseases like cancer and autoimmune disorders.
Shimon Sakaguchi, a 74-year-old immunologist at Osaka University, achieved a pivotal breakthrough in 1995. He demonstrated the complexity of the immune system, identifying a previously unknown class of immune cells that protect the body from autoimmune diseases. His discovery revolutionized the understanding of immune regulation.
Mary E. Brunko, born in 1961 and working at the Institute for Systems Biology in Seattle, and Fred Ramsdell, 64, at Sonoma Biotherapeutics, a biotechnology company in San Francisco, made another key discovery in 2001. They observed that a particular strain of mice was unusually susceptible to autoimmune diseases. Further investigation revealed that these mice carried a mutation in a gene they named “Foxp3.”
The Nobel Committee further highlighted that Brunko and Ramsdell demonstrated that mutations in the human equivalent of the Foxp3 gene cause a severe autoimmune disease called IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome). IPEX is a rare but life-threatening condition that affects multiple organ systems.
The work of Brunko, Ramsdell and Sakaguchi has profound implications for treating a wide range of diseases. By understanding how regulatory T cells function, researchers can develop new therapies to enhance immune responses against cancer cells or suppress immune responses in autoimmune diseases. These discoveries represent a significant step forward in the fight against diseases that affect millions worldwide. The Nobel Prize recognizes their invaluable contributions to science and medicine, paving the way for future advancements in immunotherapy and autoimmune disease treatment. These breakthroughs offer hope for more effective and targeted therapies for patients suffering from a variety of immune-related conditions, promising a better quality of life.
Related: More news articles on DZWatch
Source: External reference
